Washington DC, December 3, 2007 - AACC announces its 21st annual San Diego Conference which will be held at Loews Coronado Bay Resort and Spa on March 25-26, 2008. This year, the topic is ‘Genomic Technologies at the Interface of Diagnostics and Therapeutics’ which will examine how molecular and genetic tools can be the catalyst of synergy in the combined field of diagnostics and therapeutics/drug discovery.
Twenty years ago, as the San Diego Conference was being established, researchers and scientists were just beginning to develop the tools now known as “molecular diagnostics” that transferred molecular research methods into clinical practice. San Diego Conference participants were among the first to hear about these new technologies. In 2008, leading researchers, including a Nobel Prize winner and a representative from the Bill and Melinda Gates Foundation Global Health Program, will explain the implications of RNAi on human disease and health care, outline advanced tools for characterizing and sequencing DNA and novel applications of molecular tools in diagnostics and therapeutics. The faculty will also discuss the FDA perspective on regulation of multivariate index assays (MIAs).
AACC invites members of the press to participate in the conference at no charge. Journalists can register by emailing Peter Patterson.
More information about the conference is available on the AACC website at or by contacting Peter Patterson.